Occupation: Advisory Board
Advisory Board Member
Mike Molinari is Managing Director, Australia of IP Group. IP Group is a leader in the commercialisation of scientific innovation developed in research universities in the UK and the US. In Australia and New Zealand, IP Group is partnered with each of the Go8 universities and the University of Auckland, and has committed to invest a minimum of $200M in projects arising from these universities.
Immediately prior to his current role, Mike was an Investment Manager with Brandon Capital, a leading investor in Australian biotechnology and manager of the Medical Research Commercialisation Fund. Previous roles include a previous stint with IP Group as Director of IP Capital in the UK, and strategy roles with McKinsey and Company and Cricket Australia.
Mike holds a DPhil and MSc in Biomedical Engineering from the University of Oxford, where he was a recipient of the Fairfax Scholarship, and undergraduate degrees in Chemical Engineering and Science (Chemistry, Biochemistry and Molecular Biology) from the University of Melbourne.